<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effect of a novel <z:chebi fb="0" ids="27288">vinca alkaloid</z:chebi> derivative, vinconate, against brain damage after focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by a middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion in rats </plain></SENT>
<SENT sid="2" pm="."><plain>2 </plain></SENT>
<SENT sid="3" pm="."><plain>Persistent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by 6 hr, and vinconate (50 and 100 mg/kg) was given intraperitoneally twice 10 min and 3 hr after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>3 </plain></SENT>
<SENT sid="5" pm="."><plain>Focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> produced the disturbance of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, the increase of water content and the impairment of protein synthesis in the surrounding occluded <z:chebi fb="70" ids="34342">MCA</z:chebi> territory </plain></SENT>
<SENT sid="6" pm="."><plain>4 </plain></SENT>
<SENT sid="7" pm="."><plain>Vinconate was effective in preventing marked reduction of cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization in the areas surrounding the occluded <z:chebi fb="70" ids="34342">MCA</z:chebi> territory </plain></SENT>
<SENT sid="8" pm="."><plain>5 </plain></SENT>
<SENT sid="9" pm="."><plain>Vinconate significantly reduced an increase of water content in the surrounding the occluded <z:chebi fb="70" ids="34342">MCA</z:chebi> territory </plain></SENT>
<SENT sid="10" pm="."><plain>6 </plain></SENT>
<SENT sid="11" pm="."><plain>Preliminary L-[<z:chebi fb="36" ids="29309">methyl</z:chebi>-14C]methionine autoradiographic study also indicated that vinconate can partly prevent a severe impairment of protein synthesis after focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>7 </plain></SENT>
<SENT sid="13" pm="."><plain>The results indicate that vinconate may ameliorate the disturbance of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, <z:hpo ids='HP_0002181'>brain edema</z:hpo> and the impairment of protein synthesis after persistent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and they also suggest that vinconate has a beneficial effect against brain damage </plain></SENT>
</text></document>